Su Hsiu-Wei, Yi Yu-Chiao, Tseng Jenn-Jhy, Chen Wei-Chih, Chen Ya-Fang, Kung Hsiao-Fan, Chou Min-Min
Department of Obstetrics, Gynecology and Women's Health, Taichung Veterans General Hospital, Taichung, School of Medicine, National Yang Ming University, Taiwan.
Department of Obstetrics, Gynecology and Women's Health, Taichung Veterans General Hospital, Taichung, School of Medicine, National Yang Ming University, Taiwan.
Taiwan J Obstet Gynecol. 2017 Jun;56(3):353-357. doi: 10.1016/j.tjog.2017.04.016.
The purpose of this study was to describe our preliminary experience of the efficacy and safety of a conservative strategy for abnormally invasive placenta.
A retrospective review of eight pregnant women with abnormally invasive placenta (one with placenta previa accrete, three with placenta previa increta, and four with previa percreta) was performed. The diagnosis was made by prenatal ultrasonography, and was confirmed by operative and histopathological findings. Patients who desired future fertility or who had extensive diseases were selected as candidates after panel meeting. Conservative management after obtaining informed consent was defined by a primary cesarean delivery before 35 weeks of gestation with the abnormally adherent placenta left in situ, partially or totally. The primary outcome was successful uterine preservation. The secondary outcome was severe maternal morbidity including sepsis, coagulopathy, immediate or delayed hemorrhage bladder injury, and fistula.
Among the eight patients, the mean age was 34 ± 3 years (range, 30-40 years). All women had risk factors, such as placental previa, previous cesarean delivery and/or dilation & curettage, for abnormally invasive placenta. Seven women underwent planned cesarean delivery at the mean gestation age of 34 weeks (range, 31-37 weeks). One woman received hysterotomy at 18 weeks. In our series, the uterus was preserved in only two cases (25%), one who received hysterotomy at a relatively young gestational age and another who had mild disease. Mean maternal blood loss during primary cesarean delivery was 528 ± 499 ml (range, 100 ml-1,500 ml). Severe maternal morbidity was recorded in seven out of eight patients (87.5%).
In this small series, we observed a low successful uterine preservation rate and a high maternal complication rate. We recommend that primary cesarean hysterectomy should be used as the treatment of choice for mild to severe abnormally invasive placenta. Conservative management should be reserved for women with a strong fertility desire and women with extensive disease that precludes primary hysterectomy due to surgical difficulty.
本研究旨在描述我们对异常侵入性胎盘采用保守治疗策略的有效性和安全性的初步经验。
对8例异常侵入性胎盘孕妇(1例胎盘植入、3例胎盘植入加深、4例穿透性胎盘前置)进行回顾性分析。诊断通过产前超声检查做出,并经手术及组织病理学检查证实。经专家小组讨论后,选择有生育意愿或患有广泛性疾病的患者作为候选对象。在获得知情同意后,保守治疗定义为在妊娠35周前进行初次剖宫产,将异常附着的胎盘部分或全部留在原位。主要结局是成功保留子宫。次要结局是严重的孕产妇并发症,包括败血症、凝血病、即刻或延迟出血、膀胱损伤和瘘管。
8例患者的平均年龄为34±3岁(范围30 - 40岁)。所有女性均有异常侵入性胎盘的危险因素,如前置胎盘、既往剖宫产和/或刮宫术。7名女性在平均妊娠34周(范围31 - 37周)时接受了计划剖宫产。1名女性在18周时接受了子宫切开术。在我们的系列研究中,仅2例(25%)成功保留了子宫,1例在相对年轻的孕周接受了子宫切开术,另1例病情较轻。初次剖宫产时产妇平均失血量为528±499毫升(范围100毫升 - 1500毫升)。8例患者中有7例(87.5%)出现严重的孕产妇并发症。
在这个小样本系列中,我们观察到子宫保留成功率低,孕产妇并发症发生率高。我们建议,对于轻至重度异常侵入性胎盘,应首选初次剖宫产子宫切除术。保守治疗应仅适用于有强烈生育意愿且因手术困难而无法进行初次子宫切除术的广泛性疾病女性。